Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Nexgel (NXGL) EBITDA (2018 - 2025)

Historic EBITDA for Nexgel (NXGL) over the last 8 years, with Q3 2025 value amounting to -$725000.0.

  • Nexgel's EBITDA rose 799.49% to -$725000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.0 million, marking a year-over-year increase of 2423.7%. This contributed to the annual value of -$3.6 million for FY2024, which is 221.46% down from last year.
  • Latest data reveals that Nexgel reported EBITDA of -$725000.0 as of Q3 2025, which was up 799.49% from -$636000.0 recorded in Q2 2025.
  • In the past 5 years, Nexgel's EBITDA ranged from a high of -$520000.0 in Q1 2021 and a low of -$1.2 million during Q4 2023
  • Over the past 5 years, Nexgel's median EBITDA value was -$782500.0 (recorded in 2024), while the average stood at -$794722.2.
  • In the last 5 years, Nexgel's EBITDA plummeted by 7000.0% in 2022 and then surged by 4098.36% in 2023.
  • Over the past 5 years, Nexgel's EBITDA (Quarter) stood at -$887000.0 in 2021, then fell by 16.91% to -$1.0 million in 2022, then fell by 17.55% to -$1.2 million in 2023, then soared by 31.01% to -$841000.0 in 2024, then rose by 13.79% to -$725000.0 in 2025.
  • Its EBITDA stands at -$725000.0 for Q3 2025, versus -$636000.0 for Q2 2025 and -$777000.0 for Q1 2025.